LncRNAs and CircRNAs in Cancer

Overview

Journal MedComm (2020)

Specialty Health Services

Date 2022 May 20

PMID 35592755

Authors

Xin Yin

Huiran Lin

Lei Lin

Lei Miao

Jing He

Zhenjian Zhuo

Affiliations

Soon will be listed here.

Abstract

It is well known that noncoding RNAs (ncRNAs) cannot encode proteins, but they can play important regulatory roles in tumors by combining with proteins, RNAs, and DNAs. As more and more studies reveal the important roles and underlying mechanisms of long noncoding RNAs (lncRNAs) and circular RNAs (circRNAs) in cancer, their huge application potential in cancer therapy cannot be ignored. For example, lncRNAs can be involved in tumor-related signal transduction pathways, cell cycle control, DNA damage, epigenetic regulation, and microRNA control. A group of studies confirmed that abnormal expression of lncRNAs can affect cancer progression. Furthermore, as covalently closed continuous circular ncRNAs, many recent studies have shown that circRNAs have regulatory effects and other important biological significances in cancer. Interestingly, circRNAs were found to have translational functions. This has greatly attracted people's attention to circRNAs research. In this review, we introduce the important roles of lncRNAs and circRNAs in some representative cancers, respectively. Furthermore, we focus on the biological functions and important clinical therapeutic implications of lnRNAs and circRNAs in neuroblastoma. Our review also focuses on providing rationale and relevant references for novel biomarkers for neuroblastoma diagnosis, prognosis, and treatment.

Citing Articles

piRNAs and circRNAs acting as diagnostic biomarkers in clear cell renal cell carcinoma.

Xu Y, Liu H, Zhang Y, Luo J, Li H, Lai C Sci Rep. 2025; 15(1):7774.

PMID: 40044829 PMC: 11882777. DOI: 10.1038/s41598-025-90874-8.

Decoding the Promise and Challenges of miRNA-Based Cancer Therapies: An Essential Update on miR-21, miR-34, and miR-155.

Qian H, Maghsoudloo M, Jabbarzadeh Kaboli P, Babaeizad A, Cui Y, Fu J Int J Med Sci. 2024; 21(14):2781-2798.

PMID: 39512697 PMC: 11539376. DOI: 10.7150/ijms.102123.

Dysregulation of circular RNAs in inflammation and cancers.

Liu J, Zhao F, Chen L, Su S Fundam Res. 2024; 3(5):683-691.

PMID: 38933304 PMC: 11197579. DOI: 10.1016/j.fmre.2023.04.019.

Advanced approaches of the use of circRNAs as a replacement for cancer therapy.

Faraj G, Hussen B, Abdullah S, Rasul M, Hajiesmaeili Y, Baniahmad A Noncoding RNA Res. 2024; 9(3):811-830.

PMID: 38590433 PMC: 10999493. DOI: 10.1016/j.ncrna.2024.03.012.

Long non-coding RNAs in cancer: multifaceted roles and potential targets for immunotherapy.

Kadian L, Verma D, Lohani N, Yadav R, Ranga S, Gulshan G Mol Cell Biochem. 2024; 479(12):3229-3254.

PMID: 38413478 DOI: 10.1007/s11010-024-04933-1.

References

Papachristou D, Korpetinou A, Giannopoulou E, Antonacopoulou A, Papadaki H, Grivas P . Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomas. Virchows Arch. 2011; 459(4):431-40. DOI: 10.1007/s00428-011-1119-5. View

Du P, Zhao H, Peng R, Liu Q, Yuan J, Peng G . LncRNA-XIST interacts with to modulate the chemoresistance of glioma cell to TMZ through DNA mismatch repair pathway. Biosci Rep. 2017; 37(5). PMC: 5587918. DOI: 10.1042/BSR20170696. View

Li X, Zhang Z, Jiang H, Li Q, Wang R, Pan H . Circular RNA circPVT1 Promotes Proliferation and Invasion Through Sponging miR-125b and Activating E2F2 Signaling in Non-Small Cell Lung Cancer. Cell Physiol Biochem. 2018; 51(5):2324-2340. DOI: 10.1159/000495876. View

Klingenberg M, Gross M, Goyal A, Polycarpou-Schwarz M, Miersch T, Ernst A . The Long Noncoding RNA Cancer Susceptibility 9 and RNA Binding Protein Heterogeneous Nuclear Ribonucleoprotein L Form a Complex and Coregulate Genes Linked to AKT Signaling. Hepatology. 2018; 68(5):1817-1832. DOI: 10.1002/hep.30102. View

Shen Z, Zhou L, Zhang C, Xu J . Reduction of circular RNA Foxo3 promotes prostate cancer progression and chemoresistance to docetaxel. Cancer Lett. 2019; 468:88-101. DOI: 10.1016/j.canlet.2019.10.006. View

Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P . Breast cancer. Nat Rev Dis Primers. 2019; 5(1):66. DOI: 10.1038/s41572-019-0111-2. View

Zhang J, Li W, Yang Y, Yan L, Zhang S, He J . LncRNA XIST facilitates cell growth, migration and invasion via modulating H3 histone methylation of DKK1 in neuroblastoma. Cell Cycle. 2019; 18(16):1882-1892. PMC: 6681787. DOI: 10.1080/15384101.2019.1632134. View

Alderton G . Tumorigenesis: the origins of glioma. Nat Rev Cancer. 2011; 11(9):627. DOI: 10.1038/nrc3129. View

Ostrom Q, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J . CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Neuro Oncol. 2014; 16 Suppl 4:iv1-63. PMC: 4193675. DOI: 10.1093/neuonc/nou223. View

10.

Wang K, Chang H . Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011; 43(6):904-14. PMC: 3199020. DOI: 10.1016/j.molcel.2011.08.018. View

11.

Xu P, Zhang X, Cao J, Yang J, Chen Z, Wang W . The novel role of circular RNA ST3GAL6 on blocking gastric cancer malignant behaviours through autophagy regulated by the FOXP2/MET/mTOR axis. Clin Transl Med. 2022; 12(1):e707. PMC: 8782491. DOI: 10.1002/ctm2.707. View

12.

Wrensch M, Jenkins R, Chang J, Yeh R, Xiao Y, Decker P . Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet. 2009; 41(8):905-8. PMC: 2923561. DOI: 10.1038/ng.408. View

13.

Wang H, Li M, Cui H, Song X, Sha Q . CircDHDDS/miR-361-3p/WNT3A Axis Promotes the Development of Retinoblastoma by Regulating Proliferation, Cell Cycle, Migration, and Invasion of Retinoblastoma Cells. Neurochem Res. 2020; 45(11):2691-2702. DOI: 10.1007/s11064-020-03112-0. View

14.

Yerukala Sathipati S, Sahu D, Huang H, Lin Y, Ho S . Identification and characterization of the lncRNA signature associated with overall survival in patients with neuroblastoma. Sci Rep. 2019; 9(1):5125. PMC: 6435792. DOI: 10.1038/s41598-019-41553-y. View

15.

Simpson E, Brown H . Understanding osteosarcomas. JAAPA. 2018; 31(8):15-19. DOI: 10.1097/01.JAA.0000541477.24116.8d. View

16.

Yang A, Liu X, Liu P, Feng Y, Liu H, Gao S . LncRNA UCA1 promotes development of gastric cancer via the miR-145/MYO6 axis. Cell Mol Biol Lett. 2021; 26(1):33. PMC: 8268585. DOI: 10.1186/s11658-021-00275-8. View

17.

Ku G, Kang Y, Yu S, Park J, Park S, Jeong I . LncRNA LINC00240 suppresses invasion and migration in non-small cell lung cancer by sponging miR-7-5p. BMC Cancer. 2021; 21(1):44. PMC: 7796488. DOI: 10.1186/s12885-020-07755-8. View

18.

Coughlan D, Gianferante M, Lynch C, Stevens J, Harlan L . Treatment and survival of childhood neuroblastoma: Evidence from a population-based study in the United States. Pediatr Hematol Oncol. 2017; 34(5):320-330. PMC: 6764456. DOI: 10.1080/08880018.2017.1373315. View

19.

Jiang P, Wang P, Sun X, Yuan Z, Zhan R, Ma X . Knockdown of long noncoding RNA H19 sensitizes human glioma cells to temozolomide therapy. Onco Targets Ther. 2016; 9:3501-9. PMC: 4913544. DOI: 10.2147/OTT.S96278. View

20.

Xu L, Zhu S, Tang A, Liu W . LncRNA MBLN1-AS1 inhibits the progression of retinoblastoma through targeting miR-338-5p-Wnt/β-catenin signaling pathway. Inflamm Res. 2021; 70(2):217-227. DOI: 10.1007/s00011-020-01432-z. View